Skip to content
zameds

Ergocalciferol, nicotinamide, thiamine, vitamin a, vitamin b2, vitamin c (Norstan-multivitamin)

Ergocalciferol, nicotinamide, thiamine, vitamin a, vitamin b2, vitamin c

Hoechst Marion Roussel Ltd

Every registration of this product has been cancelled.

Registration

Applicant
Hoechst Marion Roussel Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Norstan-multivitamin tablet

EACH TABLET CONTAINS ERGOCALCIFEROL A 100 IU NICOTINAMIDE A 7,5 mg THIAMINE HYDROCHLORIDE A 1 mg VITAMIN A ACETATE A 5 mg VITAMIN B2 A 0,50 mg VITAMIN C A 25 mg

TabletH2094CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Vitamin b1

    • and derivatives thereof
    • in preparations thereof for injection; (S0)
    • except in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

    Consolidated Schedules 06 July 2026, lines 4392 to 4397

  • S3: Vitamin b2

    • and derivatives thereof
    • in preparations thereof for injection; (S0)
    • except in oral preparations or mixtures containing more than 100 mg of Vitamin B2 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

    Consolidated Schedules 06 July 2026, lines 4399 to 4404

  • S3: Vitamin c

    • in preparations thereof for injection; (S0)
    • except in oral preparations or mixtures containing more than 1000 mg of Vitamin C per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

    Consolidated Schedules 06 July 2026, lines 4435 to 4440

  • S3: Vitamin d

    • preparations thereof for injection and oral preparations and mixtures thereof containing more than 1 000 I.U. per recommended daily dose, except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947). (S0)

    Consolidated Schedules 06 July 2026, lines 4442 to 4445

  • S2: Vitamin a

    • and derivatives thereof and including retinol, retinal, retinoic acids and beta-carotene (but excluding isotretinoin) and not listed elsewhere in the Schedules, contained in preparations or mixtures containing more than 5 000 I.U (or 1 500 milligrams of the retinol equivalent or 3 000 milligrams of the beta-carotene equivalent) but not more than 10 000 I.U (or 3 000 milligrams of the retinol equivalent or 6 000 milligrams of the beta-carotene equivalent) of Vitamin A per recommended daily dose alone or in combination with other active pharmaceutical ingredients, except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agriculture Remedies and Stock Remedies Act, 1947 (Act 36 of 1947). (S0, S3)

    Consolidated Schedules 06 July 2026, lines 2755 to 2761

  • S1: Nicotinamide

    • and derivatives thereof, in oral preparations or mixtures containing more than 500 mg of Nicotinamide per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S0)

    Consolidated Schedules 06 July 2026, lines 886 to 888

  • S1: Vitamin b1

    • and derivatives thereof
    • in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
    • except in preparations thereof for injection. (S3)

    Consolidated Schedules 06 July 2026, lines 1149 to 1154

  • S1: Vitamin b2

    • and derivatives thereof
    • in oral preparations or mixtures containing more than 100 mg of Vitamin B2 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
    • except in preparations thereof for injection. (S3)

    Consolidated Schedules 06 July 2026, lines 1156 to 1161

  • S1: Vitamin c

    • in oral preparations or mixtures containing more than 1000 mg of Vitamin C per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
    • except in preparations thereof for injection. (S3)

    Consolidated Schedules 06 July 2026, lines 1184 to 1189

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles